Medtronic Quick Ratio 2010-2024 | MDT
Historical quick ratio values for Medtronic (MDT) over the last 10 years.
| Medtronic Quick Ratio Historical Data | |||
|---|---|---|---|
| Date | Current Assets - Inventory | Current Liabilities | Quick Ratio |
| 2024-04-30 | $16.72B | $10.79B | 1.55 |
| 2024-01-31 | $16.79B | $9.79B | 1.71 |
| 2023-10-31 | $16.33B | $9.66B | 1.69 |
| 2023-07-31 | $16.20B | $9.05B | 1.79 |
| 2023-04-30 | $16.38B | $9.05B | 1.81 |
| 2023-01-31 | $19.99B | $14.42B | 1.39 |
| 2022-10-31 | $20.34B | $14.47B | 1.41 |
| 2022-07-31 | $17.33B | $14.05B | 1.23 |
| 2022-04-30 | $18.44B | $12.39B | 1.49 |
| 2022-01-31 | $18.79B | $8.93B | 2.11 |
| 2021-10-31 | $18.38B | $7.80B | 2.36 |
| 2021-07-31 | $18.15B | $7.76B | 2.34 |
| 2021-04-30 | $18.24B | $8.51B | 2.14 |
| 2021-01-31 | $21.84B | $12.53B | 1.74 |
| 2020-10-31 | $21.55B | $12.07B | 1.79 |
| 2020-07-31 | $19.96B | $13.09B | 1.53 |
| 2020-04-30 | $17.80B | $10.37B | 1.72 |
| 2020-01-31 | $19.92B | $8.74B | 2.28 |
| 2019-10-31 | $18.61B | $8.17B | 2.28 |
| 2019-07-31 | $18.77B | $8.52B | 2.20 |
| 2019-04-30 | $18.21B | $8.47B | 2.15 |
| 2019-01-31 | $17.01B | $8.85B | 1.92 |
| 2018-10-31 | $17.89B | $8.46B | 2.11 |
| 2018-07-31 | $18.78B | $9.11B | 2.06 |
| 2018-04-30 | $19.40B | $10.08B | 1.92 |
| 2018-01-31 | $22.86B | $10.93B | 2.09 |
| 2017-10-31 | $21.52B | $10.50B | 2.05 |
| 2017-07-31 | $21.24B | $15.15B | 1.40 |
| 2017-04-30 | $21.54B | $14.26B | 1.51 |
| 2017-01-31 | $18.70B | $12.67B | 1.48 |
| 2016-10-31 | $18.81B | $9.60B | 1.96 |
| 2016-07-31 | $19.92B | $7.90B | 2.52 |
| 2016-04-30 | $20.13B | $7.17B | 2.81 |
| 2016-01-31 | $24.03B | $8.14B | 2.95 |
| 2015-10-31 | $25.21B | $8.13B | 3.10 |
| 2015-07-31 | $25.74B | $7.66B | 3.36 |
| 2015-04-30 | $27.38B | $9.17B | 2.99 |
| 2015-01-31 | $36.29B | $5.61B | 6.47 |
| 2014-10-31 | $19.72B | $6.95B | 2.84 |
| 2014-07-31 | $18.93B | $5.43B | 3.49 |
| 2014-04-30 | $19.49B | $5.56B | 3.51 |
| 2014-01-31 | $18.60B | $5.63B | 3.30 |
| 2013-10-31 | $17.66B | $5.50B | 3.21 |
| 2013-07-31 | $16.31B | $4.29B | 3.81 |
| 2013-04-30 | $16.14B | $3.95B | 4.09 |
| 2013-01-31 | $7.27B | $6.96B | 1.05 |
| 2012-10-31 | $7.56B | $6.62B | 1.14 |
| 2012-07-31 | $7.33B | $5.81B | 1.26 |
| 2012-04-30 | $14.54B | $5.93B | 2.45 |
| 2012-01-31 | $7.49B | $4.56B | 1.64 |
| 2011-10-31 | $7.17B | $4.73B | 1.52 |
| 2011-07-31 | $7.48B | $4.81B | 1.56 |
| 2011-04-30 | $7.53B | $4.73B | 1.59 |
| 2011-01-31 | $8.30B | $6.41B | 1.30 |
| 2010-10-31 | $8.26B | $5.90B | 1.40 |
| 2010-07-31 | $8.42B | $5.61B | 1.50 |
| 2010-04-30 | $8.36B | $5.12B | 1.63 |
| 2010-01-31 | $6.51B | $3.79B | 1.72 |
| 2009-10-31 | $5.84B | $3.28B | 1.78 |
| 2009-07-31 | $5.79B | $3.13B | 1.85 |
| 2009-04-30 | $6.03B | $3.15B | 1.92 |
| 2009-01-31 | $5.78B | $3.17B | 1.82 |
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | Medical Products Manufacturing | $103.915B | $32.364B |
| Medtronic, Inc. acquired Ireland-based Covidien plc. The acquisition resulted in the formation of a new holding company incorporated in Ireland - Medtronic plc. The company currently generates revenues from four major segments - namely Cardiovascular Portfolio, Medical Surgical Portfolio, Neuroscience Portfolio and Diabetes. The Cardiovascular Portfolio, formerly reported as the Cardiac and Vascular Group, includes the Cardiac Rhythm & Heart Failure, Structural Heart & Aortic and Coronary & Peripheral Vascular divisions. The Medical Surgical Portfolio, formerly reported as the Minimally Invasive Therapies Group, includes the Surgical Innovations and the Respiratory, Gastrointestinal & Renal divisions. Neuroscience consists of Cranial & Spinal Technologies, Specialty The Neuroscience Portfolio, formerly reported as the Restorative Therapies Group, includes the Cranial & Spinal Technologies, Specialty Therapies, and Neuromodulation divisions. | |||
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Abbott Laboratories (ABT) | United States | $183.183B | 23.99 |
| Stryker (SYK) | United States | $129.169B | 30.94 |
| Boston Scientific (BSX) | United States | $112.541B | 35.85 |
| EssilorLuxottica (ESLOY) | France | $102.324B | 0.00 |
| Lonza Group Ag (LZAGY) | Switzerland | $40.451B | 0.00 |
| Haleon (HLN) | United Kingdom | $39.452B | 28.80 |
| ResMed (RMD) | United States | $26.766B | 25.13 |
| Terumo (TRUMY) | Japan | $24.090B | 34.02 |
| Koninklijke Philips (PHG) | Netherlands | $23.739B | 18.84 |
| Zimmer Biomet Holdings (ZBH) | United States | $22.313B | 14.25 |
| Baxter (BAX) | United States | $17.423B | 12.39 |
| Insulet (PODD) | United States | $14.284B | 63.33 |
| Demant (WILYY) | Denmark | $10.984B | 0.00 |
| Smith & Nephew SNATS (SNN) | United Kingdom | $10.977B | 0.00 |
| Bio-Rad Laboratories (BIO) | United States | $8.098B | 26.48 |
| BellRing Brands (BRBR) | United States | $7.479B | 35.18 |
| Lantheus Holdings (LNTH) | United States | $5.472B | 13.64 |
| GN Store Nord (GNNDY) | Denmark | $4.529B | 25.43 |
| Haemonetics (HAE) | United States | $4.368B | 21.54 |
| Neogen (NEOG) | United States | $3.591B | 34.54 |
| Perrigo (PRGO) | Ireland | $3.561B | 10.79 |
| Prestige Consumer Healthcare (PBH) | United States | $3.418B | 16.27 |
| Envista Holdings (NVST) | United States | $2.910B | 12.01 |
| TG Therapeutics (TGTX) | United States | $2.845B | 80.04 |
| ICU Medical (ICUI) | United States | $2.837B | 25.04 |
| Green Thumb Industries (GTBIF) | United States | $2.671B | 52.29 |
| Agios Pharmaceuticals (AGIO) | United States | $2.568B | 0.00 |
| QuidelOrtho (QDEL) | United States | $2.271B | 12.61 |
| LeMaitre Vascular (LMAT) | United States | $1.800B | 52.76 |
| Maravai LifeSciences Holdings (MRVI) | United States | $1.781B | 0.00 |
| Warby Parker (WRBY) | United States | $1.539B | 0.00 |
| InMode (INMD) | Israel | $1.514B | 8.05 |
| AdaptHealth (AHCO) | United States | $1.353B | 10.06 |
| Verano Holdings (VRNOF) | United States | $1.275B | 0.00 |
| Owens & Minor (OMI) | United States | $1.237B | 10.78 |
| AtriCure (ATRC) | United States | $1.048B | 0.00 |
| National Vision Holdings (EYE) | United States | $1.015B | 32.30 |
| BioLife Solutions (BLFS) | United States | $0.991B | 0.00 |
| Cresco Labs (CRLBF) | United States | $0.820B | 0.00 |
| Phibro Animal Health (PAHC) | United States | $0.705B | 15.01 |
| Evolus (EOLS) | United States | $0.658B | 0.00 |
| PetIQ (PETQ) | United States | $0.647B | 20.92 |
| Surmodics (SRDX) | United States | $0.598B | 37.46 |
| VAREX IMAGING (VREX) | United States | $0.589B | 13.86 |
| Valneva SE (VALN) | France | $0.544B | 0.00 |
| Canopy Growth (CGC) | Canada | $0.525B | 0.00 |
| Quanterix (QTRX) | United States | $0.490B | 0.00 |
| Jin Medical (ZJYL) | China | $0.457B | 0.00 |
| Biote (BTMD) | United States | $0.456B | 10.50 |
| TerrAscend (TSNDF) | Canada | $0.434B | 0.00 |
| ZimVie (ZIMV) | United States | $0.404B | 34.40 |
| OraSure Technologies (OSUR) | United States | $0.317B | 10.19 |
| Cerus (CERS) | United States | $0.312B | 0.00 |
| MacroGenics (MGNX) | United States | $0.282B | 0.00 |
| Zynex (ZYXI) | United States | $0.278B | 38.00 |
| Aurora Cannabis (ACB) | Canada | $0.278B | 0.00 |
| Ayr Wellness (AYRWF) | United States | $0.254B | 0.00 |
| Sanara MedTech (SMTI) | United States | $0.250B | 0.00 |
| Viemed Healthcare (VMD) | United States | $0.248B | 24.61 |
| Omeros (OMER) | United States | $0.237B | 0.00 |
| Utah Medical Products (UTMD) | United States | $0.235B | 14.79 |
| High Tide (HITI) | Canada | $0.183B | 0.00 |
| Organigram Holdings (OGI) | Canada | $0.163B | 0.00 |
| TriSalus Life Sciences (TLSI) | United States | $0.158B | 0.00 |
| Capricor Therapeutics (CAPR) | United States | $0.153B | 0.00 |
| Eagleford Energy (GRUSF) | United States | $0.152B | 73.00 |
| FitLife Brands (FTLF) | United States | $0.151B | 21.43 |
| Quipt Home Medical (QIPT) | United States | $0.132B | 0.00 |
| Veru (VERU) | United States | $0.125B | 0.00 |
| Jushi Holdings (JUSHF) | United States | $0.118B | 0.00 |
| Brainsway (BWAY) | Israel | $0.107B | 0.00 |
| Cellectar Biosciences (CLRB) | United States | $0.103B | 0.00 |
| Fonar (FONR) | United States | $0.096B | 9.74 |
| InterCure (INCR) | Israel | $0.094B | 15.92 |
| Allurion Technologies (ALUR) | United States | $0.091B | 0.00 |
| Oramed Pharmaceuticals (ORMP) | United States | $0.091B | 0.00 |
| Chimerix (CMRX) | United States | $0.081B | 0.00 |
| MariMed (MRMD) | United States | $0.073B | 0.00 |
| Safety Shot (SHOT) | United States | $0.059B | 0.00 |
| Eagle Pharmaceuticals (EGRX) | United States | $0.058B | 3.80 |
| Bright Green (BGXX) | United States | $0.056B | 0.00 |
| Rockwell Medical (RMTI) | United States | $0.056B | 0.00 |
| Zevia PBC (ZVIA) | United States | $0.050B | 0.00 |
| Apyx Medical (APYX) | United States | $0.047B | 0.00 |
| United-Guardian (UG) | United States | $0.042B | 15.25 |
| Cytosorbents (CTSO) | United States | $0.042B | 0.00 |
| ImmuCell (ICCC) | United States | $0.035B | 0.00 |
| Modular Medical (MODD) | United States | $0.034B | 0.00 |
| Exagen (XGN) | United States | $0.033B | 0.00 |
| Nephros (NEPH) | United States | $0.022B | 0.00 |
| Meihua Medical Technologies (MHUA) | China | $0.022B | 0.00 |
| Trinity Biotech (TRIB) | Ireland | $0.018B | 0.00 |
| Agape ATP (ATPC) | $0.017B | 0.00 | |
| GUARDION HEALTH (GHSI) | United States | $0.013B | 0.00 |
| GlucoTrack (GCTK) | United States | $0.013B | 0.00 |
| Flora Growth (FLGC) | United States | $0.012B | 0.00 |
| Innovative Eyewear (LUCY) | United States | $0.008B | 0.00 |
| NeuroMetrix (NURO) | United States | $0.008B | 0.00 |
| FSD PHARMA (HUGE) | Canada | $0.007B | 0.00 |
| IM Cannabis (IMCC) | Canada | $0.007B | 0.00 |
| Leafly Holdings (LFLY) | United States | $0.006B | 0.00 |
| Sharps Technology (STSS) | United States | $0.004B | 0.00 |
| Senestech (SNES) | United States | $0.003B | 0.00 |
| Lucy Scientific Discovery (LSDI) | Canada | $0.001B | 0.00 |
| Akanda (AKAN) | United Kingdom | $0.001B | 0.00 |
| Smart For Life (SMFL) | United States | $0.000B | 0.00 |
| Bruush Oral Care (BRSH) | $0.000B | 0.00 | |
| SNDL (SNDL) | Canada | $0.000B | 0.00 |